HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manifestations and treatment of ocular syphilis during an epidemic in France.

AbstractOBJECTIVES:
To review cases of ocular syphilis presenting to a tertiary uveitis clinic during a syphilis epidemic in France between January 2001 and January 2004.
STUDY DESIGN:
Retrospective chart and patient database review.
RESULTS:
Ten patients who presented with symptoms and signs of uveitis tested positive for active syphilis. Some of the patients also presented with a rash or headache. Human immunodeficiency virus (HIV) antibody testing was positive in eight of the 10 patients, with CD4 cell counts >200 cells/mm3 in seven of the patients. Ocular inflammation resolved and visual acuity improved in all patients after treatment.
CONCLUSIONS:
A diagnosis of ocular syphilis should be considered in any patient with visual loss associated with a rash or headache, irrespective of the patient's CD4 cell count. Ocular syphilis in HIV-positive patients should be treated as neurosyphilis, whereas ocular syphilis in non-HIV patients can be treated as secondary syphilis.
AuthorsChristine E Parc, Sadri Chahed, Sanjay V Patel, Dominique Salmon-Ceron
JournalSexually transmitted diseases (Sex Transm Dis) Vol. 34 Issue 8 Pg. 553-6 (Aug 2007) ISSN: 0148-5717 [Print] United States
PMID17667532 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Disease Outbreaks
  • France (epidemiology)
  • HIV Infections (complications)
  • Homosexuality, Male
  • Humans
  • Male
  • Medical Records
  • Middle Aged
  • Neurosyphilis (blood, complications, diagnosis, drug therapy, epidemiology)
  • Retrospective Studies
  • Syphilis Serodiagnosis
  • Uveitis (complications, drug therapy, epidemiology, pathology)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: